当前位置：首页 > 文献互助 > 互助详情

Impaired Aryl Hydrocarbon Receptor Ligand Production by the Gut Microbiota Is a Key Factor in Metabolic Syndrome复制

正在寻求帮助 1天前 17 10 待确认 帖子自动结束时间: 2025-06-03 14:45:55

1. 请及时下载文件确认是否正确, 系统将在 2025-06-05 15:27:08 删除文件

2. 如若文件有误请驳回应助文件, 求助状态即回到求助中

3. 如若文件正确请及时点击确认, 若超过时后系统自动默认为已完结

注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规

DOI:复制

文献链接: https://doi.org/10.1016/j.cmet.2018.07.001复制

其他信息:

上一篇：Multiple myeloma

下一篇：Development of Novel Radiotheranostic Ligand with Positively Charged Unit Targeting Prostate-Specific Membrane Antigen

互助时间线

2025-05-29 15:27:08 [上传文件]

jodie0105上传了文件(zip 18.55 MB), 求助状态变成 待确认

2025-05-29 14:45:55 [发起求助]

最新发布的求助

Recent advances of FAPI PET tracers in the diagnosis of liver cancer 12小时前
Finding a needle in the haystack: ADME and pharmacokinetics/pharmacodynamics characterization and optimization towards orally available bifunctional protein degraders 13小时前
The meaning of non-criteria clinical manifestations in a real-life primary antiphospholipid syndrome cohort 13小时前
Tirzepatide as Compared with Semaglutide for the Treatment of Obesity 14小时前
Tirzepatide as Compared with Semaglutide for the Treatment of Obesity 14小时前
Nanobody–antigen interaction prediction with ensemble deep learning and prompt-based protein language models 14小时前
Deep lead optimization enveloped in protein pocket and its application in designing potent and selective ligands targeting LTK protein 14小时前
Industry Perspective on the Pharmacokinetic and Absorption, Distribution, Metabolism, and Excretion Characterization of Heterobifunctional Protein Degraders 15小时前
Long-acting injectable delivery system comprising ordered mixed drug aggregates with deaggregating and uniformly embeddable viscoelastic-polysaccharide … 15小时前
Well-posedness and Numerical Analysis of a Nonstationary Stokes Hemivariational Inequality 16小时前
Physicochemical stability of lurbinectedin reconstituted at 500 μg/mL and diluted at 15, 30, and 70 μg/mL in 0.9% sodium chloride and 5% dextrose 20小时前
An Accurate and Fast 31P qNMR Assay Method for Oligonucleotide Therapeutics 21小时前

wispass工作室 Copyright © 蜀ICP备2024051606号-2 www.wispass.com